Apogee Therapeutics, Common Stock Analysis

Apogee Stock Analysis Notes

About 89.0% of the company shares are held by institutions such as insurance companies. The book value of Apogee Therapeutics, was presently reported as 12.35. The company recorded a loss per share of 3.3. Apogee Therapeutics, had not issued any dividends in recent years. For more info on Apogee Therapeutics, Common please contact Michael MD at 650 394 5230 or go to https://www.apogeetherapeutics.com.

Apogee Therapeutics, Investment Alerts

Apogee Therapeutics, Upcoming and Recent Events

Apogee Largest EPS Surprises

View All Earnings Estimates

Apogee Therapeutics, Environmental, Social, and Governance (ESG) Scores

Apogee Therapeutics, Thematic Classifications

Apogee Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.32 B.

Apogee Profitablity

Management Efficiency

Apogee Therapeutics, has return on total asset (ROA) of (0.2346) % which means that it has lost $0.2346 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3322) %, meaning that it created substantial loss on money invested by shareholders. Apogee Therapeutics,'s management efficiency ratios could be used to measure how well Apogee Therapeutics, manages its routine affairs as well as how well it operates its assets and liabilities. As of March 26, 2025, Return On Tangible Assets is expected to decline to -0.2. In addition to that, Return On Capital Employed is expected to decline to -0.31. At present, Apogee Therapeutics,'s Other Current Assets are projected to increase significantly based on the last few years of reporting.

Technical Drivers

As of the 26th of March, Apogee Therapeutics, shows the Standard Deviation of 4.35, risk adjusted performance of (0.03), and Mean Deviation of 2.98. Apogee Therapeutics, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apogee Therapeutics, variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Apogee Therapeutics, is priced correctly, providing market reflects its regular price of 40.15 per share. Given that Apogee Therapeutics, has information ratio of (0.05), we suggest you to validate Apogee Therapeutics, Common's prevailing market performance to make sure the company can sustain itself at a future point.

Apogee Therapeutics, Price Movement Analysis

Apogee Therapeutics, Insider Trading Activities

Apogee Therapeutics, Predictive Daily Indicators

Apogee Therapeutics, Corporate Filings

Apogee Therapeutics, Forecast Models

Apogee Therapeutics,'s time-series forecasting models are one of many Apogee Therapeutics,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apogee Therapeutics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Apogee Therapeutics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apogee shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Apogee Therapeutics,. By using and applying Apogee Stock analysis, traders can create a robust methodology for identifying Apogee entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Apogee analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Apogee analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Apogee Therapeutics, Common stock analysis indicators help investors evaluate how Apogee Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Apogee Therapeutics, shares will generate the highest return on investment. By understating and applying Apogee Therapeutics, stock analysis, traders can identify Apogee Therapeutics, position entry and exit signals to maximize returns.

When running Apogee Therapeutics,'s price analysis, check to measure Apogee Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apogee Therapeutics, is operating at the current time. Most of Apogee Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Apogee Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apogee Therapeutics,'s price. Additionally, you may evaluate how the addition of Apogee Therapeutics, to your portfolios can decrease your overall portfolio volatility.